Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas

Modern Pathology

Volumn 11, Issue 1, 1998, Pages 55-59

  Brown, Daniel F ^a   Dababo, M Anas ^a   Hladik, Christa L ^a   Eagan, Kathleen P ^a   White III, Charles L ^a   Rushing, Elisabeth J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; Clear cell renal cell carcinoma; Estrogen receptor; Hemangioblastoma; Immunohistochemistry; Progesterone receptor

Indexed keywords

ANDROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; EPENDYMOMA; ESTROGEN BLOOD LEVEL; HEMANGIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MENINGIOMA; NEURILEMOMA; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID;

EID: 0031966562     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kasantikul V, Brown WJ. Estrogen receptors in acoustic neurilemmomas. Surg Neurol 1981;15:105-9.
2. Matuza RL, MacLaughlin DT, Ojemann RG. Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery 1981;9:665-71.
3. Schnegg JF, Gomez F, LeMarchand-Beraud T, de Tribolet N. Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 1981;15:415-8.
4. Concolino G, Giuffre R, Margiotta G, Liccardo G. Sex steroid hormone receptors in primary spinal tumors. Zentralbl Neurochir 1982;43:351-8.
5. Concolino G, Liccardo G, Conti C, Panfili C, Giuffre R. Hormones and tumours in central nervous system (CNS): steroid receptors in primary spinal cord tumours. Neurol Res 1984;6:121-6.
6. Concolino G, Giuffre R, Margiotta G, Liccardo G, Marocchi A. Steroid receptors in CNS: estradiol (ER) and progesterone (PR) in human spinal cord tumors. J Steroid Biochem 1984; 20:491-4.
7. Perrot-Applant M, Groyer-Picard MT, Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 1992;115:20-30.
8. Nathan L, Satin AJ, Twickler DM. Cerebellar hemangioblastoma complicating pregnancy: a case report. J Reprod Med 1995;40:662-4.
9. Martelli A, Grilli S, Soli M, De Giovanni C, Bercovich E, Galli MC, et al. Correlation between clinical response to antiandrogenic therapy and occurrence of receptors in human prostatic cancer. Urology 1980;16:245-9.
10. Geller J. Basis for hormonal management of advanced prostate cancer. Cancer 1991;71:1039-45.
11. Labrie F. Endocrine therapy for prostate cancer. Endocrinol Metab Clin North Am 1991;20:845-72.
12. Hawkins RA, Roberts MM, Forrest APM. Oestrogen receptors and breast cancer. Current status. Br J Surg 1980;67:162-5.
13. Russell DS, Rubinstein LJ. Pathology of tumors of the nervous system. 5th ed. Baltimore: Williams & Wilkins; 1989. p. 639-57.
14. Burger PC, Scheitauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings. 3rd ed. New York: Churchill Livingstone; 1991. p. 373-88.
15. Mondkar VP, McKissock W, Russell RW. Cerebellar haemangioblastomas. Br J Surg 1967;54:45-9.
16. Constans JP, Meder F, Maiuri F, Donzelli R, Spaziante R, de Divititis E. Posterior fossa hemangioblastomas. Surg Neurol 1986;25:269-75.
17. Yamashita J, Handa H, Kim C, Kim S. Familial occurrence of cerebellar hemangioblastomas: analysis of five families. Neurosurgery 1982;11:761-3.
18. Neumann HPH, Eggert HR, Weigel K, Friedberg H, Wiestler OD, Schollmyer P. Hemangioblastomas of the central nervous system. J Neurosurg 1989;70:24-30.
19. Andrew SM, Gradwell E. Immunoperoxidase-labeled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol 1986;39:917-9.
20. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol 1989;2:638-51.
21. Hufnagel TJ, Kim JH, True LD, Manuelidis EE. Immunohistochemistry of capillary hemangioblastoma: immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma but does not explain the histogenesis of the capillary hemangioblastoma. Am J Surg Pathol 1989;13:207-16.
22. Mills SE, Ross GW, Perentes E, Nakayawa Y, Scheitauer BW. Cerebellar hemangioblastoma: immunohistochemical distinction from metastatic renal cell carcinoma. Surg Pathol 1990;3:121-32.
23. Kaplan C, Sayre GP, Greene LF. Bilateral nephrogenic carcinomas in Lindau-von Hippel disease. J Urol 1961;86:36-42.
24. Malek RS, Omess PJ, Benson RC, Zince H. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987;82: 236-8.
25. Stornes I, Jorgensen TM. Renal malignancy in von Hippel-Lindau's disease. Scand J Urol Nephrol 1993;27:139-42.
26. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
27. Ogasawara KK, Ogasawara EM, Hirata G. Pregnancy complicated by von Hippel-Lindau disease. Obstet Gynecol 1995; 85:829-31.
28. Orovan WL, Rijan ED. Estrogen and progesterone binding sites in renal cell carcinoma. Urology 1989;34:65-7.
29. Sion-Vardi N, Kaneti J, Segal-Abramson T, Giat J, Levy J, Sharoni Y. Gonadotropin releasing hormone-specific binding sites in normal and malignant renal tissue. J Urol 1992; 148:1568-70.
30. Klotzl G, Otto U, Becker H, Klosterhalfen H. Determination of androgen, progestin, and estrogen receptors with two different assays in renal cell carcinoma. Urol Int 1987;42: 100-4.
31. Noronha RFX, Ramanath B. Increased dihydrotestosterone receptor levels in high-stage renal adenocarcinoma. Cancer 1985;56:134-7.
32. Nakano E, Tada Y, Fujioka H, Matsuda M, Osafune M, Kotake T, et al. Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. J Urol 1984;132:240-5.